New drug R & D related meeting summary (August September), there will always be one for you!

Medical policies have been introduced one after another, relevant regulations have been implemented, and colleagues in the pharmaceutical industry cannot wait to die At present, we have collected relevant meetings of the pharmaceutical industry in August and September to share with you There will always be a meeting for you, and we are looking forward to meeting you in a certain venue.. Meeting brief introduction 2016.8.17 2016 three keynote speeches of drug research and development and precision medical Immunoassay Technology Forum 1 The first generation solutions to common problems of ELISA and Western blot 2 Ultra sensitive, low cell consumption, fast and stable cell-ba sed detection technology and cases 3 PD-1, PD-L1 antibody drug metabolism, immunogenicity, protein marker detection 4 exhibition areas of drug exhibition area, medical equipment exhibition area, equipment and instrument exhibition area, industry science and technology and service of 2016.8.19-8.20 2016 Natural Medicine Symposium - Exploration and discovery of three topics: 1 Basic research of natural medicine; 2 Research on natural innovative drugs and leading compounds; 3 Extraction, separation and identification of natural drugs; 2 roadshows of 2016.8.21 biotechnology industry investment conference; 1 Specific topics of precise diagnosis and targeted drugs; 2 Special topics of gene and cell therapy, targeted drugs and vaccines; 8.25-8.27, 2016 The 10th China (Qingdao) international pharmaceutical APIs, intermediates, fine chemicals and technical equipment exhibition 2016 has three categories: 1 Pharmaceutical chemical equipment and new materials; 2 APIs, intermediates, chemical industry zone; 3 Fine and special chemicals; 5 special sessions of China Industrial Pharmacy and be research Summit Forum 2016.8.25-8.28; 1 CMC research field: it mainly focuses on the technical bottlenecks and difficult nodes in the consistency evaluation of bcs2 and 4 kinds of drugs, sustained and controlled release preparations, be exemptions, etc., and arranges two up to three hours of discussion and interaction to achieve the effect of reaching consensus in solving the confusion Be research field: focus on the local effects on gastrointestinal drugs, endogenous drugs, complex preparations and the pharmacodynamic indicators of be research to help solve the problems in be research 3 Auxiliary materials, instruments and equipment: high-end products and technologies at home and abroad are presented to participants, which can be customized according to their own product characteristics and prepared for the rainy day, so as to achieve twice the result with half the effort in consistency evaluation 4 Special field of technical cooperation: face to face and one-to-one exchange will be held with the keynote speaker, technical alliance of conformity assessment and technical director of the unit of training and optimization Alliance for specific cases, specific technical problems and rld filing, procurement and legal acquisition in the enterprise conformity assessment 5 Special field of exhibition and display: special field of small-scale instrument, equipment and service exhibition will be set during the meeting 2016.8.26-8.28 three special lectures on conformity training of drug production process and application for approval production process 1 How to ensure the consistency of application process and mass production process 2 Research on change of drug registration process and supplementary application 3 Sorting and improvement of application materials related to drug production process 2016.8.26-8.28 Five contents of the special training course of generic drug registration review and consistency evaluation and self inspection and verification of drug clinical trial data: 1 Generic drug consistency evaluation strategy and technical requirements of be research; 2 Key technologies of generic drug consistency evaluation and the prospect of preparation innovation in the new situation; 3 Response methods after promoting consistency evaluation in Taiwan; 4 Current situation of be implementation in Taiwan and advantages of cross strait cooperative clinical practice 5 Self inspection and verification of drug clinical trial data 2016.8.27-8.28 two main contents of agenda notice of practical operation Seminar on consistency evaluation from pharmacy to clinical practice 1 Policy discussion and pharmaceutical practice 2 Interpretation and cooperation of be and clinical research policy 2016.8.27-8.29 the way to director of BD (Business Development) of preeminent medicine 4 items: 1 Martial arts script of excellent medical BD Director 2 Pharmaceutical business cooperation scenario show 3 Operation of multinational BD department and cross-border BD transaction 4 How to build a win-win transaction between biotechnology and pharmaceutical enterprises? 2016.9.2-9.3 pharmaceutical industry project roadshow forum and investment of Nobel laureate medical summit 1 International Biomedical Industry Forum 2 Project docking private meeting (50 projects at home and abroad) 3 On site roadshow (8 minutes each, 30 projects at home and abroad) 2016.9.3-9.4 medicine BD Huangpu college and entering excellent pharmaceutical enterprises series activities - Wuhan qiruichang new drug introduction and transaction training 1 Value and significance of cooperative transaction (BD) in Biotechnology Enterprises 2 Redefinition and evaluation of target value under intensive new policies 3 Valuation logic and valuation model in biopharmaceutical transaction 4 Precautions in the process of selection and introduction of innovative drug projects 2 items on data reliability and flight inspection practice of new GMP recertification on September 3-9, 2016 1 Prospect and data reliability practice of pharmaceutical data management specification in Appendix of computerized system 2 Notice on normalization of flight inspection and recertification of new GMP 2016.9.9 Lao Liang said that medicine Shanghai Zhangjiang party readers Shanghai party 2016.9.16-9.18 the third round notice of the second international viral tumor and new drug research and Development Summit Forum 2 topics 1 DNA tumor virus 2 Hepatitis virus and HCC 2016.9.21-9.22 How to cut in 14 keynote speeches from innovation Frontier: 1 Skills from the development of PARP inhibitors 2 International innovative drug project standard, discovery method and development strategy 3 Opportunities and risks of new drug investment from innovation frontier to Chinese new drug investment 4 Looking at the new opportunities of innovative drug investment and financing from the trend of new drug research and development 2016.9.22-9.24 the Fifth China rare disease Summit Forum rare disease comprehensive conference 1 Rare disease medical insurance practice and negotiation mechanism 2 Gene detection industry specification and clinical application 3 New progress in rare disease diagnosis and treatment in China 4 Orphan drug research and development and market access 2016.9.24-9.25 drug data management specification / aseptic simulation filling / CSV and data reliability practice / flight inspection and hot issues training 5 contents 1 Drug data management specification and "aseptic medium simulation filling and sterilization filtration technology" 2 New trends of GMP inspection 3 Ubiquitous risk management 4 Seamless data reliability vulnerability 5 Confusion in New appendix 2016.9.28 application of structural identification in the field of medicine, chemical industry and materials 2 Application of structural identification in the field of medicine, chemical industry and materials 2 Supercritical fluid chromatography for the separation of chiral compounds There may be omissions in the statistics of the conference Welcome to add.